Harnessing Folate-Functionalized Nasal Delivery of Dox–Erlo-Loaded Biopolymeric Nanoparticles in Cancer Treatment: Development, Optimization, Characterization, and Biodistribution Analysis

The aim of the present study is to develop Doxorubicin–Erlotinib nanoparticles (Dox–Erlo NPs) and folate-armored Dox–Erlo-NP conjugates for targeting glioma cancer. Glioma is one of the most common progressive cancerous growths originating from brain glial cells. However, the blood–brain barrier (BB...

Descripción completa

Detalles Bibliográficos
Autores principales: Farheen, Ms, Akhter, Md Habban, Chitme, Havagiray, Akhter, Md Sayeed, Tabassum, Fauzia, Jaremko, Mariusz, Emwas, Abdul-Hamid
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9959140/
https://www.ncbi.nlm.nih.gov/pubmed/37259356
http://dx.doi.org/10.3390/ph16020207

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9959140/
https://www.ncbi.nlm.nih.gov/pubmed/37259356
http://dx.doi.org/10.3390/ph16020207

Ejemplares similares